Guardant Health, Inc.
Guardant Health, Inc. (GH) Stock Overview
Explore Guardant Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
12.6B
P/E Ratio
-28.63
EPS (TTM)
$-3.40
ROE
1.84%
GH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Guardant Health, Inc. (GH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 56.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $132.91.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -28.63 and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.